Short-term toxicogenomics as an alternative approach to chronic in vivo studies for derivation of points of departure: A case study in the rat with a triazole fungicide
- 1 June 2020
- journal article
- research article
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 113, 104655
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Incorporating New Technologies Into Toxicity Testing and Risk Assessment: Moving From 21st Century Vision to a Data-Driven FrameworkToxicological Sciences, 2013
- Accurate determination of tissue steroid hormones, precursors and conjugates in adult male ratThe Journal of Biochemistry, 2012
- Introduction to benchmark dose methods and U.S. EPA's benchmark dose software (BMDS) version 2.1.1Toxicology and Applied Pharmacology, 2011
- Application of Transcriptional Benchmark Dose Values in Quantitative Cancer and Noncancer Risk AssessmentToxicological Sciences, 2010
- Mode of Action for Reproductive and Hepatic Toxicity Inferred from a Genomic Study of Triazole AntifungalsToxicological Sciences, 2009
- Disruption of Testosterone Homeostasis as a Mode of Action for the Reproductive Toxicity of Triazole Fungicides in the Male RatToxicological Sciences, 2006
- Gene expression profiling in liver and testis of rats to characterize the toxicity of triazole fungicidesToxicology and Applied Pharmacology, 2006
- Metabolism of myclobutanil and triadimefon by human and rat cytochrome P450 enzymes and liver microsomesXenobiotica, 2006
- A Statistical Evaluation of Toxicity Study Designs for the Estimation of the Benchmark Dose in Continuous EndpointsToxicological Sciences, 2004
- Procedures for Detecting Outlying Observations in SamplesTechnometrics, 1969